pI: 4.8886 |
Length (AA): 287 |
MW (Da): 30917 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
8 | 280 | 2q74 (A) | 5 | 286 | 27.00 | 0 | 1 | 1.22702 | -0.31 |
9 | 274 | 4as4 (A) | 3 | 267 | 32.00 | 0 | 1 | 1.41363 | -0.92 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126810)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G31190 | myo-inositol monophosphatase like 1 |
Arabidopsis thaliana | AT3G02870 | L-galactose-1-phosphate phosphatase |
Brugia malayi | Bm1_48905 | Inositol-1 |
Caenorhabditis elegans | CELE_F13G3.5 | Protein TTX-7, isoform B |
Dictyostelium discoideum | DDB_G0281239 | inositol monophosphatase |
Drosophila melanogaster | Dmel_CG17027 | CG17027 gene product from transcript CG17027-RB |
Drosophila melanogaster | Dmel_CG17026 | CG17026 gene product from transcript CG17026-RA |
Drosophila melanogaster | Dmel_CG9391 | CG9391 gene product from transcript CG9391-RC |
Drosophila melanogaster | Dmel_CG17028 | CG17028 gene product from transcript CG17028-RA |
Drosophila melanogaster | Dmel_CG17029 | CG17029 gene product from transcript CG17029-RB |
Drosophila melanogaster | Dmel_CG9389 | CG9389 gene product from transcript CG9389-RA |
Escherichia coli | b2533 | inositol monophosphatase |
Echinococcus granulosus | EgrG_000451900 | inositol monophosphatase 1 |
Entamoeba histolytica | EHI_175410 | myo-inositol monophosphatase, putative |
Echinococcus multilocularis | EmuJ_000451900 | inositol monophosphatase 1 |
Homo sapiens | 3612 | inositol(myo)-1(or 4)-monophosphatase 1 |
Homo sapiens | ENSG00000141401 | inositol(myo)-1(or 4)-monophosphatase 2 |
Leishmania braziliensis | LbrM.17.1530 | myo-inositol-1(or 4)-monophosphatase 1, putative |
Leishmania donovani | LdBPK_171510.1 | myo-inositol-1(or 4)-monophosphatase 1, putative |
Leishmania infantum | LinJ.17.1510 | myo-inositol-1(or 4)-monophosphatase 1, putative |
Leishmania major | LmjF.17.1390 | myo-inositol-1(or 4)-monophosphatase 1, putative |
Leishmania mexicana | LmxM.17.1390 | myo-inositol-1(or 4)-monophosphatase 1, putative |
Loa Loa (eye worm) | LOAG_03630 | inositol-1 |
Mycobacterium leprae | ML1024 | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). |
Mus musculus | 55980 | inositol (myo)-1(or 4)-monophosphatase 1 |
Mus musculus | ENSMUSG00000024525 | inositol (myo)-1(or 4)-monophosphatase 2 |
Mycobacterium tuberculosis | Rv2701c | Inositol-1-monophosphatase SuhB |
Mycobacterium ulcerans | MUL_3339 | extragenic suppressor protein SuhB |
Neospora caninum | NCLIV_006000 | hypothetical protein |
Oryza sativa | 4333347 | Os03g0587000 |
Oryza sativa | 4328439 | Os02g0169900 |
Saccharomyces cerevisiae | YDR287W | inositol monophosphate 1-phosphatase INM2 |
Saccharomyces cerevisiae | YHR046C | inositol monophosphate 1-phosphatase INM1 |
Schistosoma japonicum | Sjp_0211780 | ko:K01092 myo-inositol-1(or 4)-monophosphatase [EC3.1.3.25], putative |
Schistosoma mansoni | Smp_095000.1 | inositol monophosphatase |
Schistosoma mansoni | Smp_095000.2 | inositol monophosphatase |
Schmidtea mediterranea | mk4.006138.00 | Inositol monophosphatase |
Schmidtea mediterranea | mk4.002736.02 | |
Schmidtea mediterranea | mk4.018767.00 | Inositol monophosphatase ttx-7 |
Schmidtea mediterranea | mk4.002736.01 | |
Schmidtea mediterranea | mk4.012486.00 | Inositol monophosphatase ttx-7 |
Schmidtea mediterranea | mk4.010837.00 | Inositol monophosphatase |
Trypanosoma brucei gambiense | Tbg972.5.3780 | inositol-1(or 4)-monophosphatase 1, putative |
Trypanosoma brucei | Tb927.5.2690 | inositol-1(or 4)-monophosphatase 1, putative |
Trypanosoma congolense | TcIL3000_5_2780 | inositol-1(or 4)-monophosphatase 1, putative |
Trypanosoma cruzi | TcCLB.507047.120 | myo-inositol-1(or 4)-monophosphatase 1, putative |
Trypanosoma cruzi | TcCLB.509179.140 | myo-inositol-1(or 4)-monophosphatase 1, putative |
Toxoplasma gondii | TGME49_222970 | inositol(myo)-1(or 4)-monophosphatase 2, putative |
Trichomonas vaginalis | TVAG_144540 | inositol monophosphatase, putative |
Trichomonas vaginalis | TVAG_372100 | myo inositol monophosphatase, putative |
Trichomonas vaginalis | TVAG_051080 | myo inositol monophosphatase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0132 | fructose-1,6-bisphosphatase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.2690 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.2690 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.2690 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.2690 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2533 | Escherichia coli | essential | goodall |
TGME49_222970 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Bos taurus | Inositol-1(or 4)-monophosphatase 1 | Compounds | References |
Rattus norvegicus | Inositol monophosphatase 1 | Compounds | References |